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Abstract
7,12-dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles in a concentration-dependent manner.
The impact of DMBA on connexin (CX) proteins that mediate communication between follicular cell types
along with pro-apoptotic factors p53 and Bax were investigated. Postnatal day (PND) 4 Fisher 344 rat ovaries
were cultured for 4 days in vehicle medium (1% DMSO) followed by a single exposure to vehicle control (1%
DMSO) or DMBA (12.5 nM or 75 nM) and cultured for 4 or 8 days. RT-PCR was performed to quantify
Cx37, Cx43, p53 and Bax mRNA level. Western blotting and immunofluorescence staining were performed to
determine CX37 or CX43 level and/or localization. Cx37 mRNA and protein increased (P < 0.05) at 4 days
of 12.5 nM DMBA exposure. Relative to vehicle control-treated ovaries, mRNA encoding Cx43 decreased (P
< 0.05) but CX43 protein increased (P < 0.05) at 4 days by both DMBA exposures. mRNA expression of pro-
apoptotic p53 was decreased (P < 0.05) but no changes in Bax expression were observed after 4 days of
DMBA exposures. In contrast, after 8 days, DMBA decreased Cx37 and Cx43 mRNA and protein but
increased both p53 and Bax mRNA levels. CX43 protein was located between granulosa cells, while CX37
was located at the oocyte cell surface of all follicle stages. These findings support that DMBA exposure
impacts ovarian Cx37 and Cx43 mRNA and protein prior to both observed changes in pro-apoptotic p53 and
Bax and follicle loss. It is possible that such interference in follicular cell communication is detrimental to
follicle viability, and may play a role in DMBA-induced follicular atresia.
Keywords
Ovary, DMBA, Ovotoxicity, Connexins, Gap Junctions, Follicle
Disciplines
Animal Experimentation and Research | Animal Sciences | Cell and Developmental Biology | Genetics |
Molecular Genetics
Comments
This is a manuscript of an article published as Ganesan, Shanthi, and Aileen F. Keating. "Impact of 7,
12-dimethylbenz [a] anthracene exposure on connexin gap junction proteins in cultured rat ovaries."
Toxicology and applied pharmacology 274, no. 2 (2014): 209-214. doi: 10.1016/j.taap.2013.11.008. Posted
with permission.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0
License.
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/ans_pubs/475
Impact of 7,12-dimethylbenz[a]anthracene exposure on connexin
gap junction proteins in cultured rat ovaries
Shanthi Ganesan and Aileen F. Keating*
Department of Animal Science, Iowa State University, Ames, IA 50011, USA
Abstract
7,12-dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles in a concentration-dependent
manner. The impact of DMBA on connexin (CX) proteins that mediate communication between
follicular cell types along with pro-apoptotic factors p53 and Bax were investigated. Postnatal day
(PND) 4 Fisher 344 rat ovaries were cultured for 4 days in vehicle medium (1% DMSO) followed
by a single exposure to vehicle control (1% DMSO) or DMBA (12.5 nM or 75 nM) and cultured
for 4 or 8 days. RT-PCR was performed to quantify Cx37, Cx43, p53 and Bax mRNA level.
Western blotting and immunofluorescence staining were performed to determine CX37 or CX43
level and/or localization. Cx37 mRNA and protein increased (P < 0.05) at 4 days of 12.5 nM
DMBA exposure. Relative to vehicle control-treated ovaries, mRNA encoding Cx43 decreased (P
< 0.05) but CX43 protein increased (P < 0.05) at 4 days by both DMBA exposures. mRNA
expression of pro-apoptotic p53 was decreased (P < 0.05) but no changes in Bax expression were
observed after 4 days of DMBA exposures. In contrast, after 8 days, DMBA decreased Cx37 and
Cx43 mRNA and protein but increased both p53 and Bax mRNA levels. CX43 protein was located
between granulosa cells, while CX37 was located at the oocyte cell surface of all follicle stages.
These findings support that DMBA exposure impacts ovarian Cx37 and Cx43 mRNA and protein
prior to both observed changes in pro-apoptotic p53 and Bax and follicle loss. It is possible that
such interference in follicular cell communication is detrimental to follicle viability, and may play
a role in DMBA-induced follicular atresia.
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Introduction
The female gamete, the oocyte, is encased in a follicular structure surrounded by granulosa
cells and, as the follicle matures, also by theca cells. Primordial follicles are maintained in a
dormant state until activation into the growing follicular pool (Hirshfield, 1991). In women,
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nearly 99% of ovarian follicles undergo degenerative changes by a process known as atresia
(Hirshfield, 1991) and ovarian senescence (menopause) occurs when the finite pool of
primordial follicles has become exhausted (Mattison and Nightingale, 1982; Broekmans et
al., 2007; Hansen et al., 2008). Since primordial follicles cannot be regenerated (Hirshfield,
1991), chemical-induced depletion of this follicle pool can lead to infertility and premature
ovarian failure (POF). A number of chemical classes can deplete follicles causing
ovotoxicity, including the polycyclic aromatic hydrocarbon, 7,12-
dimethylbenz[a]anthracene (DMBA) (Mattison, 1980; Hoyer et al., 2009; Igawa et al.,
2009). Since DMBA can induce DNA double strand break (DSBs) damage in oocytes and
granulosa cells (Ganesan et al., 2013), there is concern that exposure could lead to negative
consequences for offspring should this damage be improperly repaired.
DSBs activate ataxia-telangiectasia mutated (ATM) protein which phosphorylates p53, a
tumor suppressor protein. p53 can then activate DNA repair proteins, induce cell cycle arrest
or initiate apoptosis if the DNA damage proves to be irreparable. Phosphorylated p53
activates a number of downstream pro-apoptotic molecules including Bax (Lane, 1992).
BAX promotes apoptosis by binding to and antagonizing the action of BCL-2 protein,
resulting in release of cytochrome c and activation of caspases to induce apoptosis (Weng et
al., 2005). We and others have previously demonstrated that ovaries exposed to DMBA
have increased levels of caspase 3 protein (Tsai-Turton et al., 2007; Ganesan et al., 2013).
Additionally, BAX-deficient mice ovaries are resistant to DMBA-induced primordial
follicle destruction (Matikainen et al., 2001).
Granulosa:granulosa and granulosa:oocyte cell to cell communication are necessary for
maintenance of follicular viability. Communication between these cells occurs through gap
junction intra-cellular channels, which directly connect the cytoplasmic compartments of
neighboring cells and allow exchange of ions, metabolites and second messenger such as
Ca2+ and inositol phosphates (Goldberg et al., 2004). Gap junctions are involved in
regulation of cellular growth, metabolism and differentiation (Sohl and Willecke, 2003; Wei
et al., 2004) and ovarian folliculogenesis (Simon et al., 2006). The major ovarian gap
junction proteins are connexin (CX) 37 and 43 (Kidder and Mhawi, 2002a). CX37
communicates from the oocyte to granulosa cell (Simon et al., 1997), while CX43 functions
in intra-granulosa cell communication (Granot et al., 2002; Kidder and Mhawi, 2002a).
CX37 is thought to be involved in follicular development and ovulation as well as luteal
tissue growth, differentiation, and regression (Borowczyk et al., 2006). Cx37-null mouse
oocytes suffer growth retardation and do not survive to become meiotically competent
(Carabatsos et al., 2000). Follicle growth is also interrupted: Cx37−/− granulosa cells form
structures resembling corpora lutea in the absence of ovulation. CX43 levels are increased in
granulosa cells following activation of follicular growth and maturation (Melton et al.,
2001), while reduced granulosa cell expression of CX43 is linked to elevated apoptosis in
porcine, bovine (Johnson et al., 1999; Cheng et al., 2005) and avian (Krysko et al., 2004)
species. Thus, CX37 and CX43 play important roles in the ovary to maintain follicular and
oocyte viability and quality.
Little is known about the impact of ovotoxicant exposures on ovarian function, thus in this
study we investigated any impact of DMBA on ovarian gap junction genes Cx37 and Cx43
along with the pro-apoptotic cellular components, p53 and Bax. We utilized a neonatal rat
whole ovary culture method to determine the effect of a single DMBA exposure at two
concentrations – 12.5 nM and 75 nM, since we have previously shown that these
concentrations induce DNA damage and increased caspase 3 levels 8 days after exposure
(Ganesan et al., 2013). Also, we have observed that these DMBA concentrations induced
large primary and secondary follicle loss (unpublished data). Our hypothesis was that
DMBA would alter Cx37 and Cx43 at time points prior to changes in pro-apoptotic genes
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7,12-Dimethylbenz[a]anthracene (DMBA; CAS # 57-97-6), bovine serum albumin (BSA),
ascorbic acid, transferrin, 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide,
ammonium persulphate, glycerol, N’N’N’N’-Tetramethylethylenediamine (TEMED), Tris
base, Tris HCL, Sodium chloride, Tween-20 were purchased from Sigma-Aldrich Inc. (St
Louis, MO). Dulbecco’s Modified Eagle Medium:nutrient mixture F-12 (Ham) 1x (DMEM/
Ham’s F12), Albumax, penicillin (5000U/ml), Hanks’ Balanced Salt Solution (without
CaCl2, MgCl2 orMgSO4) from Invitrogen Co. (Carlsbad, CA). Millicell-CM filter inserts
and 48 well cell culture plates were obtained from Millipore (Bedford, MA) and Corning
Inc. (Corning, NY) respectively. RNeasy Mini kit, QIA shredder kit, RNeasy Min Elute kit,
and Quantitect TM SYBR Green PCR kit were purchased from Qiagen Inc (Valencia, CA).
All primers were purchased from the Iowa State University DNA facility. All primary
antibodies were purchased from Abcam (Cambridge, MA). RNA later was obtained from
Ambion Inc. (Austin, TX). Goat anti-rabbit secondary antibodies were obtained from Santa
Cruz Biotechnology, (Santa Cruz, CA). Ponceau S was from Fisher Scientific. ECL plus
chemical luminescence detection kit was obtained from GE Healthcare, Amersham
(Buckinghamshire, UK). Primers were obtained from the DNA facility of the Office of
Biotechnology at Iowa State University (Ames, IA).
Ovary culture
Ovaries were collected from PND4 Fisher 344 female rats and cultured as described
previously (Devine et al., 2002). Briefly, PND4 female F344 rat pups were euthanized by
CO2 inhalation followed by decapitation. Ovaries were removed, trimmed of oviduct and
other excess tissues and placed onto membrane floating on 250 μl of DMEM/Ham’s F12
medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 μg/ml ascorbic acid, 5 U/ml
penicillin and 27.5 μg/ml transferrin per well in a 48 well plate that had previously been
equilibrated to 37 °C. A drop of medium was placed on top of each ovary to prevent it from
drying. Ovaries were cultured for 4 days in control medium to allow development of large
primary and secondary follicles, and were then treated once with medium containing vehicle
control (1% DMSO) ± DMBA (12.5 nM or 75 nM) and the culture was maintained for four
or eight days at 37 °C and 5% CO2. These exposures have been found in our laboratory to
induce large primary and/or secondary follicles after 8 days (unpublished data).
Additionally, 75 nM DMBA was shown to cause primordial follicle loss after 15 days of
exposure on alternate days, while the 12.5 nM exposure did not affect primordial follicle
number (Igawa et al., 2009). Thus, the purpose of these experiments was to investigate the
impact of DMBA exposures on large primary and secondary follicles. The medium was
replaced every two days. One ovary per animal was placed in control medium, while the
contralateral ovary was exposed to the experimental treatment.
RNA isolation and Quantitative RT-PCR
RNA was isolated using an RNeasy Mini kit (Qiagen) and the concentration was determined
using an ND-1000 Spectrophotometer (λ = 260/280nm; NanoDrop technologies, Inc.,
Wilmington, DE) (n=3; 10 ovaries per pool). Total RNA (200 ng) was reverse transcribed to
cDNA utilizing the Superscript III One-Step RT-PCR (Qiagen). cDNA was diluted (1:20) in
RNase-free water. Diluted cDNA (2μl) were amplified on an Eppendorf PCR Master cycler
using Quantitect SYBR Green PCR kit (Qiagen). Primers were designed by Primer 3 Input
Version (0.4.0); Cx37 forward - tgatcacaggtggttctgga; Cx37 reverse - aggagaagtggggtgtgatg:
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Cx43 forward - gagcgaggtttcaacagtgc; Cx43 reverse - ccgaacacgacagcagttta: Gapdh forward
- gtggacctcatggcctacat; Gapdh reverse – ggatggaattgtgagggaga: p53 forward –
tggtccagcaaatcctatc; p53 reverse – gagtggaggaaatgggtcct: Bax forward –
cgagctgatcagaaccatca; Bax reverse – ctcagcccatcttcttccag. The regular cycling program
consisted of a 15-min hold at 95°C and 45 cycles of denaturing at 95°C for 15s, annealing at
58°C for 15s, and extension at 72°C for 20s at which point data were acquired. There was no
difference in Gapdh mRNA expression between treatments, thus each sample was
normalized to Gapdh before quantification. Quantification of fold-change in gene expression
was performed using the 2−ΔΔCt method (Livak and Schmittgen, 2001; Pfaffl, 2001).
Expression level for control was set at 1, and treatment gene changes were expressed as
fold-change relative to the vehicle control treated ovaries. Thus, fold-changes presented are
increases above the control value of 1.
Protein isolation and Western blotting
Protein was isolated from cultured ovaries (n=3; 10 ovaries per pool). Homogenates were
prepared from cultured ovaries via homogenization in tissue lysis buffer containing protease
and phosphatase inhibitors as previously described (Thompson et al., 2005). Briefly,
homogenized samples were placed on ice for 30 min, followed by two rounds of
centrifugation at 10,000 rpm for 15 min and protein concentration was measured using a
BCA protocol. Protein was stored at −80 °C until further use. SDS-PAGE was used to
separate protein homogenates which were then transferred to a nitrocellulose membrane.
Membranes were blocked for 1 hour in 5 % milk in Tris-buffered saline containing tween
20, followed by incubation with anti-rabbit CX37 or CX43 antibody (1:100) for 36 h at 4°C.
Following three washes in TTBS (1X), membranes were incubated with species-specific
secondary antibodies (1:2000) for 1 h at room temperature. Membranes were washed 3X in
TTBS and incubated in chemiluminescence detection substrate (ECL plus) for 5 min
followed by X-ray film exposure. Densitometry of the appropriate bands was performed
using ImageJ software (NCBI). Equal protein loading was confirmed by Ponceau S staining
of membranes and protein level was normalized to Ponceau S densitometry values.
Immunofluorescence Staining
Ovaries were fixed in 4% paraformaldehyde for 2 h, transferred to 70% ethanol, embedded
in paraffin, serially sectioned (5 μM thick), and every 10th section was mounted. Slides
were deparaffinized in xylene and rehydrated with subsequent washes in ethanol. Antigen
retrieval was carried out by microwaving sections for 7 min in sodium citrate buffer (1M,
pH 6.1). Sections were then blocked in 5% BSA for 1 h at room temperature. Sections were
incubated with primary antibody CX37 (1:200) and CX43 (1:200) overnight at 4°C. After
washing in 1% PBS, sections were incubated with the appropriate goat anti-rabbit IgG-FITC
secondary antibodies for 1 h. Slides were then counterstained with 4-6-diamidino-2-
phenylindole (DAPI) or Hoechst for 5 min. Images were taken using a Leica fluorescent
microscope and protein expression were analyzed using ImageJ software (NCBI). 10-15
follicles per ovary (n=3) were analyzed for CX37 protein quantification and 3 ovaries were
used to quantify CX 43 protein level by counting the number of CX43 positive foci in each
ovary.
Statistical analysis
Raw data were analyzed by paired t-tests where two treatments were compared or ANOVA
for comparison of more than two treatments, comparing treatment with control using
Graphpad Prism 5.04 software. Values are expressed as mean ± SE; n=3 (10 ovaries per
pool). Statistical significance was defined as * = P < 0.05
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Effect of DMBA on Cx37 and Cx43 mRNA level
DMBA exposure increased (P < 0.05) Cx37 mRNA (12.5 nM: 3.4-fold ± 0.9; 75 nM: 1.4-
fold ± 0.9) at 4 days of exposure. In contrast, DMBA decreased (P < 0.05) Cx43 mRNA
(12.5 nM: 0.5-fold ± 0.004; 75 nM: 0.7-fold ± 0.2), compared to vehicle-treated ovaries at 4
days of exposure (Figure 1A). At 8 days, both Cx37 and Cx43 mRNA expression were
decreased (P < 0.05) by 12.5 nM (Cx37: 0.9-fold ± 0.007; Cx43: 0.85-fold ± 0.008) and 75
nM (Cx37: 0.95-fold ± 0.04; Cx43: 0.95-fold ± 0.06) DMBA compared to vehicle-treated
ovaries (Figure 1B).
Impact of DMBA on CX37 and CX43 protein level
CX37 protein level was increased (P < 0.05) by 12.5 nM and decreased (P < 0.05) by 75 nM
DMBA at 4 days, relative to vehicle-treated ovaries. CX43 protein level was increased (P <
0.05) by 12.5 nM and by 75 nM DMBA at 4 days, relative to vehicle-treated ovaries (Figure
2A).
At 8 days, CX37 was decreased (P < 0.05) by 12.5 nM compared to vehicle-treated ovaries,
but there was no impact of 75 nM DMBA on CX37. CX43 protein level was decreased (P <
0.05) by 12.5 nM and by 75 nM DMBA compared to vehicle-treated ovaries (Figure 2B).
Localization and amount of ovarian CX37 and CX43 proteins and impact of DMBA thereon
CX37 (Figure 3A-C) was localized to the oocyte cell surface. At 8 days, CX37 protein
staining was increased (P < 0.05) in small primary follicles by 12.5 nM ompared to 75 nM
and vehicle-treated ovaries and in large primary and secondary follicles, CX37 was
decreased (P < 0.05) by 12.5 nM and by 75 nM DMBA exposures, relative to vehicle-
treated ovaries, respectively (Figure 3H). CX43 (Figure 3D-F) was localized to the
granulosa cells of all follicular stages. CX43 total protein staining was decreased (P < 0.05)
by 12.5 nM and 75 nM DMBA exposures compared to vehicle-treated ovaries at 8 days
(Figure 3G). In follicles that were devoid of oocytes, CX43 protein localization was absent
or negligible.
DMBA effect on p53 and Bax mRNA level
Relative to vehicle-treated ovaries, DMBA exposure decreased (P < 0.05) p53 mRNA (12.5
nM: 0.7-fold ± 0.04; 75 nM: 0.6-fold ± 0.1) after 4 days of exposure (Figure 4A). In
contrast, DMBA increased (P < 0.05) p53 mRNA (12.5nM: 0.6-fold ± 0.1; 75 nM: 0.4-fold
± 0.09), compared to vehicle-treated ovaries after 8 days of exposure (Figure 4B)
DMBA exposure did not affect Bax mRNA after 4 days of exposure (Figure 4C). In contrast,
DMBA increased (P < 0.05) Bax mRNA (12.5nM: 0.9-fold ± 0.08; 75 nM: 0.8-fold ± 0.1),
compared to vehicle-treated ovaries after 8 days of exposure (Figure 4D).
Discussion
DMBA is an ovotoxicant that depletes follicles at various stages of development (Rajapaksa
et al., 2007; Igawa et al., 2009). The initiating event in DMBA-induced follicle destruction
remains unclear; however, since cell to cell communication is vital for follicular viability, it
is possible that perturbation to communication within the follicle could have detrimental
consequences for the oocyte. CX37 and CX43 are the major ovarian gap junction proteins,
shown to be essential for folliculogenesis and production of fertilizable oocytes (Granot et
al., 2002; Kidder and Mhawi, 2002b; Teilmann, 2005). There is little information on
whether ovotoxic chemicals target CX proteins and communication within the follicle, thus,
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we investigated whether DMBA had any impact on Cx37 and Cx43. Prior to DMBA-
induced follicle loss, Cx37 mRNA and protein was increased and although Cx43 protein was
elevated, mRNA encoding the Cx43 gene was decreased. These data indicate that DMBA
may target Cx43 at the transcriptional level initially, and that increased Cx37 mRNA and
protein and CX43 protein may be part of the ovarian protective response to DMBA
exposure. Both Cx37 and Cx43 mRNA and protein were decreased by DMBA exposures at
8 days. This time coincides with DMBA-induced follicle depletion (unpublished data) and
therefore may simply be a consequence of reduced follicle number.
Cx37-null mice display retarded oocyte growth (Carabatsos et al., 2000) due to lack of
nutrient intake from extracellular environment (Eppig, 1991). We found that CX37 protein
was localized to the oocyte cell surface, in agreement with a previous report in the mouse
ovary (Teilmann, 2005; Simon et al., 2006). Lack of organized CX37 localization around
the oocyte perimeter has been reported as an early sign of follicular atresia (Teilmann,
2005), thus, the perturbations to Cx37 mRNA and protein could impact follicular viability
during DMBA-induced ovotoxicity. We did not observe obvious localization changes in
CX37, however, interestingly, increased CX37 protein was evident in the small primary
follicles at 12.5 nM DMBA. Since small primary follicle numbers are not impacted by
DMBA at this concentration (unpublished data), it is possible that increased CX37 is
protective against DMBA-induced follicle loss.
Cx43 mRNA and protein level are correlated with follicular development in immature rats
(Granot and Dekel, 1997). In extra-ovarian tissues, CX43 is inversely correlated with
apoptosis, acting as a survival factor (Lin et al., 2003). The increase in Cx43 mRNA level
after 4 days of DMBA exposure potentially indicates an anti-apoptotic role for ovarian
CX43. Consistent with this posit, at the time point when follicle loss was observed
(unpublished data), Cx43 mRNA and protein were decreased by DMBA exposure which is
consistent with lower expression of Cx43 mRNA and protein expression in cryopreserved
apoptotic mouse ovarian tissue (Lee et al., 2008). This decrease in Cx43 mRNA and protein
is also associated with increased caspase 3 protein in ovaries treated with the same DMBA
concentrations (Ganesan et al., 2013). An elevated level of apoptosis associated with low
expression of CX43 has also been reported in avian granulosa cells (Krysko et al., 2004).
CX43 protein was localized between the granulosa cells in all stage follicles, consistent with
a previous study that reported CX43 localization in the gap junctions connecting rat ovarian
granulosa cells, with highest expression in pre-mature and pre-ovulatory antral follicles
(Okuma et al., 1996; Gittens and Kidder, 2005). Interestingly, in large primary and
secondary follicles that were devoid of oocytes, CX43 protein was either absent or
negligible, implying that some oocyte-derived factor may be involved in CX43 protein
maintenance. Despite our observed reduction of CX43 protein from total protein
homogenates, the number of CX43 positive foci was increased. This may be representative
of an attempt to increase gap junction communication and promote survival.
We also found increased levels of pro-apoptotic p53 and Bax at the time of follicle loss (8
days) but not before the time of follicle loss (4 days). Thus, DMBA-induced changes in the
Cx37 and Cx43 genes occurred prior to changes in pro-apoptotic components. Decreased
p53 prior to follicle loss could be due to interaction of p53 with mdm2, resulting in p53
inhibition (Lakin and Jackson, 1999). Additionally, there was no induction of Bax until the
time-point at which follicle loss was observed (day 8). These results are in agreement with
another study that demonstrated increased pro-apoptotic BAX and caspase-3 in granulosa
cells of DMBA-exposed pre-ovulatory follicles (Tsai-Turton et al., 2007). Future work
would include examining whether post-translational changes to BAX and p53 proteins occur
during DMBA exposure.
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In summary, DMBA alters ovarian Cx37 and Cx43 at the transcriptional and post-
transcriptional levels. The initial increase in CX37 and CX43 proteins in response to DMBA
exposure demonstrates the capacity of ovarian tissue to mount a compensatory response to
an ovotoxic insult.
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DMBA increases Cx37 and Cx43 expression prior to follicle loss
During follicle loss both Cx37 and Cx43 expression are reduced
CX43 protein is absent in follicle remnants lacking an oocyte
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Figure 1. Effect of DMBA exposure on Cx37 and Cx43 mRNA expression
Total RNA was isolated from PND4 rat ovaries that were cultured in vehicle control
medium for 4 days followed by a single exposure to control (CT), 12.5 or 75 nM DMBA for
(A) 4 or (B) 8 days. qRT-PCR was performed to amplify Cx37 or Cx43 mRNA. Values are
expressed as mean fold change ± SE; n=3 (10 ovaries per pool). Statistical significance was
defined as * = P < 0.05.
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Figure 2. Effect of DMBA exposure on CX37 and CX43 protein level
Total protein was isolated from PND4 rat ovaries that were cultured in vehicle control
medium for 4 days followed by a single exposure to control (CT), 12.5 or 75 nM DMBA for
(A) 4 or (B) 8 days. (C) Western blotting was performed to quantify CX37 or CX43 protein
level (day 8). Values are expressed as densitometric mean ± SE; n=3 (10 ovaries per pool).
Statistical significance was defined as * = P < 0.05.
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Figure 3. Localization of and impact of DMBA exposure on ovarian CX37 and CX43 protein
level
PND4 rat ovaries were cultured in control medium for 4 days followed by a single exposure
to vehicle control (CT), 12.5 or 75 nM DMBA for 8 days. Ovarian sections were
immunostained using primary (A-C) CX37 (green stain) or (D-F) CX43 (red stain)
antibodies to check the localization and intensity of staining. Blue staining represents
nuclear DNA staining. Thin arrows indicate primordial/small primary follicles; thick arrows
indicate large primary/secondary follicles; chevron indicates follicle lacking an oocyte.
ImageJ software was used to analyze the intensity of staining. 10-15 follicles per ovary
(n=3) were used for (G) CX37 quantification and 3 ovaries were used for (H) CX43 positive
foci quantification. Values are expressed as densitometric mean ± SE. *= P< 0.05; different
from control.
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Figure 4. Effect of DMBA exposure on p53 and Bax mRNA expression
Total RNA was isolated from PND4 rat ovaries that were cultured in vehicle control
medium for 4 days followed by a single exposure to vehicle control (CT), 12.5 or 75 nM
DMBA for (A, C) 4 or (B, D) 8 days. qRT-PCR was performed to amplify (A, B) p53 or (C,
D) Bax mRNA. Values are expressed as mean fold change ± SE; n=3 (10 ovaries per pool).
Statistical significance was defined as * = P < 0.05.
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